COLORECTAL ADMINISTRATION OF HUMAN INTERFERON-ALPHA

被引：20

作者：

BOCCI, V ^{[1
]}

NALDINI, A ^{[1
]}

CORRADESCHI, F ^{[1
]}

LENCIONI, E ^{[1
]}

机构：

[1] UNIV SIENA,FAC PHARM,DEPT PHARMACEUT SCI,I-53100 SIENA,ITALY

来源：

关键词：

D O I：

10.1016/0378-5173(85)90148-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：109 / 114

页数：6

共 11 条

[1] THE KIDNEY IS THE MAIN SITE OF INTERFERON CATABOLISM
BOCCI, V
PACINI, A
MUSCETTOLA, M
PESSINA, GP
PAULESU, L
BANDINELLI, L
[J]. JOURNAL OF INTERFERON RESEARCH, 1982, 2 (02): : 309 - 314
[2] EVALUATION OF ROUTES OF ADMINISTRATION OF INTERFERON IN CANCER - A REVIEW AND A PROPOSAL
BOCCI, V
[J]. CANCER DRUG DELIVERY, 1984, 1 (04): : 337 - 351
[3] BOCCI V, 1968, INTERFERONS, P37
[4] BOCCI V, 1985, INTERFERON IN VIVO C, V4, P47
[5] AN ASSESSMENT OF ANTIVIRAL DRUGS FOR THE MANAGEMENT OF INFECTIOUS-DISEASES IN HUMANS
GALASSO, GJ
[J]. ANTIVIRAL RESEARCH, 1981, 1 (02) : 73 - 96
[6] GARDNER CR, 1983, B TECH GATTEFOSSE RE, V78, P16
[7] Langford M P, 1981, Methods Enzymol, V78, P339
[8] LEVIN S, 1982, LANCET, V1, P592
[9] RITSCHEL WA, 1983, B TECH GATTEFOSSE RE, V78, P18
[10] VLATKOVIC R, 1979, PRESS S INTERFERON, P173